 |
|
|
|
Therapeutic Classes :
NMDA antagonist for Alzheimer's
Indication : Moderate to severe dementia of the Alzheimerˇ¦s type
Content :
memantine 10mg
|
|
Advantage :
1.The only approved NMDA receptor antagonist to treat moderate to severe Alzheimerˇ¦s disease.
2.Effectively defer the disease progression, limit the deterioration of recognition, improve the quality of life and reduce the cost on medical care.
Package:
.
Other:
|
|
|
|
